Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

J&J COVID-19 vaccine pause to be reviewed by U.S. panel next week

CoronavirusApr 16, 2021 02:55PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Johnson & Johnson COVID-19 vaccine is administered in Bay Shore, NY

By Manas Mishra and Carl O'Donnell

(Reuters) - A U.S. panel will meet again next week to discuss whether the pause on the use of Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine should continue, after delaying a vote on the matter earlier this week.

The U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on April 23, a top U.S. health official said on Friday.

The continued pause "will allow additional time to review any additional cases that might come in, and for (the panel) to conduct a complete risk assessment and to evaluate the emerging science," CDC Director Dr. Rochelle Walensky said during a Friday news conference.

U.S. health regulators recommended earlier this week that use of the J&J vaccine be paused after reports of six cases of rare brain blood clots in women, out of some 7 million people who have received the shot in the United States.

The advisory panel on Wednesday called for more data before making a decision on how and whether to resume use of the one-shot vaccine.

Walensky said supply of COVID-19 vaccines from Moderna (NASDAQ:MRNA) Inc and Pfizer Inc (NYSE:PFE) will remain strong, even as administering of J&J's vaccine remains on hold.

"We continue to work with pharmacies, states and FEMA (the Federal Emergency Management Agency) to make sure the vaccine supply remains robust across the country," she said.

Reuters reported on Friday that rich countries are stocking up on Pfizer/BioNTech and Moderna shots as concerns mount about vaccines from J&J and AstraZeneca (NASDAQ:AZN) Plc.

Walensky said she is very concerned about rising U.S. COVID-19 cases driven by the relaxing of state restrictions to curb virus transmission and the spread of more contagious new coronavirus variants of COVID-19.

The U.S. seven-day average daily case count is 69,500, with hospitalizations up 5% to 8%, and daily deaths have increased for the third day in a row, Walensky added.

J&J COVID-19 vaccine pause to be reviewed by U.S. panel next week
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email